StopAfib.org Blog

StopAfib.org - For Patients. By Patients - Stop Atrial Fibrillation

Bisphosphonates for Osteoporosis May Increase Rate of Atrial Fibrillation

Are you on bisphosphonates, such as Fosamax, Boniva, Actonel, or Reclast, to prevent osteoporosis, or are you considering them? If you have atrial fibrillation, or could be at risk for it, this new study will be of interest to you. While this study found absolute risk of atrial fibrillation to be low, bisphosphonates may lead …

Read More
StopAfib.org - For Patients. By Patients - Stop Atrial Fibrillation

Heart Rate and Beta Blocker Studies For Those with Atrial Fibrillation

Recently there have been a number of new beta blocker and heart rate studies, some of which are contradictory. The findings from some of these recent studies may apply to those with atrial fibrillation: Heart rates over 70 beats per minute predict heart attack risk Slowing the heart rate doesn't protect those with hypertension—or does …

Read More
StopAfib.org - For Patients. By Patients - Stop Atrial Fibrillation

USA Weekend talks about atrial fibrillation and mini-maze surgery

USA Weekend HealthSmart edition features a story about Mellanie True Hills, founder of StopAfib.org, in which she talks about living with atrial fibrillation and communicating electronically with her surgeon before and after her mini-maze surgery. Read:  USA Weekend Talks About Atrial Fibrillation and Mini-Maze Surgery... What are your thoughts on the role that electronic communications should play in your communications …

Read More
StopAfib.org - For Patients. By Patients - Stop Atrial Fibrillation

Stopping and re-starting amiodarone for atrial fibrillation is more dangerous than continuous use

A study in the October 15 issue of JAMA indicates that reducing how often a patient receives amiodarone for atrial fibrillation does not decrease side effects, but does increase atrial fibrillation recurrence and the risk of death and hospitalizations. Read: Continuous use of amiodarone for atrial fibrillation better than episodic use

Read More